Last year, a movement of labor actions was deemed “striketober” online and on social media as union workers in healthcare and other industries walked off the job or threatened to do so. Now the possibility of another “striketober” looms amid increased …
The federal government said Sept. 23 that it will cover the cost for 60,000 doses of bebtelovimab, Eli Lilly’s COVID-19 antibody drug. The news comes about a month after the drugmaker started selling the treatment commercially for $2,000 per dose.
From a projected gastroenterologist shortage to a salary reduction, here are five numbers gastroenterology leaders should keep an eye on:
In the aftermath of the failed rollout of HealthCare.gov, the White House created the U.S. Digital Service. Charles Worthington’s job there was, as he put it, to “help the government be more awesome at delivering software.”
The herpes simplex virus has been used to shrink and kill cancer tumors in a trial in the United Kingdom, the BBC reported Sept. 23.
Less than a month after federal regulators authorized Moderna and Pfizer’s modified COVID-19 boosters for emergency use, the vaccine-makers are looking for the FDA’s OK on their pediatric version.
Mark Cuban’s pharmacy, Cost Plus Drugs, is expected to be profitable in 2023, Forbes reported Sept. 26.
Morgantown, W.Va.-based Mon Health is being sued over a December 2021 data breach, The (Morgantown) Dominion Post reported Sept. 24.
Pain Specialists of America, an interventional pain management group, has integrated the new Proclaim Plus spinal cord stimulation system with FlexBurst360 therapy for patients receiving neuromodulation therapy for chronic pain.
Nashville, Tenn.-based HCA Healthcare and Dallas-based Tenet Healthcare are seeking CFOs for several hospitals.
